Real-world evidence shows remdesivir tied to less death in hospitalized COVID patients
Overall, the hazard ratio for in-hospital mortality at 28 days was 0.73.
Related Articles
Merchant of measles: RFK Jr. must stop his anti-vaccine actions
Health and Human Services Secretary Robert F. Kennedy Jr. is doing whatever he can to undermine public health. Last week, he ordered his department to…
US funding cuts have crippled our HIV work – what’s being lost
The US cuts in research funding are devastating to the fight against HIV/Aids. It’s going to be very hard to recover.
Russia must assume responsibility for MH17 downing: UN aviation agency
The ICAO says Russia must pay damages for the downing of a Malaysian airliner over Ukraine in 2014.
HIV patients in Ukraine face treatment ‘apocalypse’ as US funds in limbo
Ukraine relies on the U.S. to fund HIV services during the war. The Trump administration is still mulling axing its support.
Self-Assembly of Nanogold Triplets on Trimeric Viral Proteins for Infectious Disease Diagnosis
Timely and accurate diagnostics for infectious diseases are essential in preventing their worldwide spread. Though rapid diagnostic tests are favored for their speed, cost-effectiveness, and…
With nearby CWD cases, Rockingham County, Virginia, added to watch list
West Virginia detected cases within 10 miles of the county border, triggering the addition, officials said.
FDA, CDC recommend pause in Valneva chikungunya vaccine for older adults
In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed to assess if the vaccine is the…
COVID-19 fueled increase in hospital-onset MRSA, study finds
While incidence of community-associated and healthcare-associated community-onset MRSA bacteremia declined during the pandemic, hospital-onset cases rose substantially.
Korean study links early antibiotic use to higher risk of early puberty in girls
Antibiotic use in the first 3 month of life was associated with a 23% increase in risk of early puberty in girls.
Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A pair of new studies highlight respiratory syncytial virus (RSV) in US adults, with one estimating 75% vaccine effectiveness (VE)…